Catalyst Pharmaceuticals (CPRX) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free CPRX Stock Alerts $16.81 +0.32 (+1.94%) (As of 03:46 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Catalyst Pharmaceuticals Short Interest DataCurrent Short Interest7,710,000 sharesPrevious Short Interest6,270,000 sharesChange Vs. Previous Month+22.97%Dollar Volume Sold Short$116.04 millionShort Interest Ratio5.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares118,110,000 sharesFloat Size101,640,000 sharesShort Percent of Float7.59%Today's Trading Volume469,057 sharesAverage Trading Volume1,410,235 sharesToday's Volume Vs. Average33% Short Selling Catalyst Pharmaceuticals ? Sign up to receive the latest short interest report for Catalyst Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCPRX Short Interest Over TimeCPRX Days to Cover Over TimeCPRX Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Catalyst Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20247,710,000 shares $116.04 million +23.0%7.6%5.9 $15.05 4/15/20246,270,000 shares $96.50 million +3.6%6.2%4.7 $15.39 3/31/20246,050,000 shares $96.44 million +3.8%6.1%4.1 $15.94 3/15/20245,830,000 shares $93.69 million -9.9%5.8%3.9 $16.07 2/29/20246,470,000 shares $103.71 million +14.1%6.5%4.3 $16.03 2/15/20245,670,000 shares $78.76 million +20.9%6.2%4.1 $13.89 Get the Latest News and Ratings for CPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Catalyst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,690,000 shares $67.54 million -21.3%5.1%3.3 $14.40 1/15/20245,960,000 shares $86.36 million +5.9%6.5%4 $14.49 12/31/20235,630,000 shares $94.64 million -21.6%6.1%4 $16.81 12/15/20237,180,000 shares $103.25 million +4.7%7.9%5.8 $14.38 11/30/20236,860,000 shares $98.99 million +3.0%7.5%5.7 $14.43 11/15/20236,660,000 shares $90.91 million +3.7%7.3%5.5 $13.65 10/31/20236,420,000 shares $79.67 million +2.4%7.0%5.2 $12.41 10/15/20236,270,000 shares $80.13 million -1.3%6.8%5.2 $12.78 9/30/20236,350,000 shares $74.23 million -20.0%6.9%5.2 $11.69 9/15/20237,940,000 shares $98.93 million +10.9%8.7%6.2 $12.46 8/31/20237,160,000 shares $100.53 million +6.1%7.2%4.7 $14.04 8/15/20236,750,000 shares $101.12 million +2.4%6.8%4.2 $14.98 7/31/20236,590,000 shares $91.14 million -8.3%6.6%3.5 $13.83 7/15/20237,190,000 shares $92.46 million -9.1%7.2%3.7 $12.86 6/30/20237,910,000 shares $106.31 million -6.2%8.0%4 $13.44 6/15/20238,430,000 shares $104.28 million -8.0%8.5%4.3 $12.37 5/31/20239,160,000 shares $105.80 million -3.5%9.2%4.7 $11.55 5/15/20239,490,000 shares $124.70 million -15.2%9.6%4.9 $13.14 4/30/202311,190,000 shares $178.14 million +2.2%11.2%6.5 $15.92 4/15/202310,950,000 shares $193.71 million -3.4%11.0%5 $17.69 3/31/202311,330,000 shares $187.85 million +15.9%11.4%5 $16.58 3/15/20239,780,000 shares $140.25 million -5.7%9.9%4.1 $14.34 2/28/202310,370,000 shares $158.25 million +6.5%10.6%4.4 $15.26 2/15/20239,740,000 shares $149.61 million +12.9%10.0%3.8 $15.36 1/31/20238,630,000 shares $133.68 million -15.3%8.8%3.1 $15.49 1/15/202310,190,000 shares $214.50 million -3.0%10.4%3.9 $21.05 12/30/202210,510,000 shares $195.49 million +38.8%10.8%4.7 $18.60 12/15/20227,570,000 shares $127.48 million -4.2%7.7%3.2 $16.84 11/30/20227,900,000 shares $132.48 million +18.4%8.1%2.5 $16.77 11/15/20226,670,000 shares $105.99 million -17.3%6.8%2 $15.89 10/31/20228,060,000 shares $111.79 million -7.6%8.4%2.5 $13.87 10/15/20228,720,000 shares $109.44 million -3.8%9.0%2.7 $12.55 9/30/20229,060,000 shares $116.24 million +82.3%9.4%2.7 $12.83 9/15/20224,970,000 shares $67.69 million -20.1%5.2%1.5 $13.62Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now 8/31/20226,220,000 shares $84.22 million -8.4%6.6%2.9 $13.54 8/15/20226,790,000 shares $96.62 million -3.7%7.2%3.7 $14.23 7/31/20227,050,000 shares $72.19 million -20.3%7.4%4.5 $10.24 7/15/20228,840,000 shares $75.76 million -13.3%9.3%6.2 $8.57 6/30/202210,190,000 shares $71.43 million +4.3%10.7%8.8 $7.01 6/15/20229,770,000 shares $63.60 million +11.0%10.3%8.4 $6.51 5/31/20228,800,000 shares $63.36 million +18.1%9.3%7.8 $7.20 5/15/20227,450,000 shares $51.48 million +45.8%7.8%6.4 $6.91 4/30/20225,110,000 shares $38.94 million +10.6%5.4%4.3 $7.62 4/15/20224,620,000 shares $38.85 million +1.1%4.9%4 $8.41 3/31/20224,570,000 shares $37.89 million -3.8%4.8%3.9 $8.29 3/15/20224,750,000 shares $35.82 million -9.7%5.0%4.2 $7.54 2/28/20225,260,000 shares $41.03 million +2.7%5.5%4.6 $7.80 2/15/20225,120,000 shares $39.53 million +18.2%5.4%4.6 $7.72 1/31/20224,330,000 shares $24.94 million +13.7%4.5%4 $5.76 1/15/20223,810,000 shares $23.77 million +6.1%N/A3.9 $6.24 12/31/20213,590,000 shares $24.30 million -15.1%3.8%3.9 $6.77 12/15/20214,230,000 shares $29.27 million +3.9%4.4%4.1 $6.92 11/30/20214,070,000 shares $28.49 million -2.4%4.3%4.6 $7.00 11/15/20214,170,000 shares $30.44 million -2.1%4.4%4.7 $7.30 10/29/20214,260,000 shares $25.13 million -3.4%4.5%5.1 $5.90 10/15/20214,410,000 shares $26.59 million -7.0%4.6%5.3 $6.03 9/30/20214,740,000 shares $25.12 million -9.2%5.0%5.5 $5.30 9/15/20215,220,000 shares $26.10 million -0.8%5.5%6.1 $5.00 8/31/20215,260,000 shares $28.98 million -7.4%5.5%5.5 $5.51 8/13/20215,680,000 shares $34.31 million -2.1%5.9%5.7 $6.04 7/30/20215,800,000 shares $33.87 million +1.9%6.0%5.2 $5.84 7/15/20215,690,000 shares $31.41 million -11.8%5.9%4.8 $5.52 6/30/20216,450,000 shares $37.09 million -30.2%6.7%5.2 $5.75 6/15/20219,240,000 shares $52.48 million -3.8%9.6%7.5 $5.68 5/28/20219,600,000 shares $53.09 million -9.9%10.0%7.1 $5.53 5/14/202110,660,000 shares $53.09 million -2.0%11.1%7.3 $4.98 4/30/202110,880,000 shares $51.68 million -7.1%11.3%7.2 $4.75 4/15/202111,710,000 shares $52.23 million -5.3%12.1%7 $4.46 3/31/202112,370,000 shares $53.69 million +29.5%12.8%7 $4.34 3/15/20219,550,000 shares $37.15 million +13.7%9.9%4.9 $3.89 2/26/20218,400,000 shares $32.76 million -8.8%8.7%4.5 $3.90 2/12/20219,210,000 shares $39.83 million -6.6%9.6%4.9 $4.33 1/29/20219,860,000 shares $35.50 million -2.7%10.2%5.3 $3.60 1/15/202110,130,000 shares $35.76 million -0.3%10.5%6 $3.53 12/31/202010,160,000 shares $34.75 million -17.3%10.5%6.3 $3.42 12/15/202012,280,000 shares $47.03 million -4.2%12.7%7.4 $3.83 11/30/202012,820,000 shares $47.43 million -4.6%13.3%8.4 $3.70 11/15/202013,440,000 shares $45.70 million +0.1%13.9%8.8 $3.40 10/30/202013,430,000 shares $41.77 million +4.9%13.9%7.9 $3.11 10/15/202012,800,000 shares $40.83 million -6.2%13.3%6.6 $3.19 9/30/202013,640,000 shares $40.51 million +17.2%14.2%6.9 $2.97 9/15/202011,640,000 shares $39.11 million -7.4%12.1%6.2 $3.36 8/31/202012,570,000 shares $41.23 million +2.0%13.1%6.3 $3.28 8/14/202012,330,000 shares $42.79 million +7.0%12.8%6.1 $3.47Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now 7/31/202011,520,000 shares $49.54 million -1.1%12.0%6.1 $4.30 7/15/202011,650,000 shares $57.78 million -3.6%12.1%6.8 $4.96 6/30/202012,090,000 shares $55.86 million -13.0%12.6%6.6 $4.62 6/15/202013,890,000 shares $60.98 million +8.5%14.4%7.2 $4.39 5/29/202012,800,000 shares $55.17 million -2.0%13.3%6.2 $4.31 5/15/202013,060,000 shares $55.64 million +7.0%13.6%6.1 $4.26 4/30/202012,210,000 shares $57.88 million -12.9%12.7%5.8 $4.74 4/15/202014,010,000 shares $60.94 million +1.4%14.6%6.7 $4.35 3/31/202013,820,000 shares $69.38 million -1.5%14.4%6.4 $5.02 3/13/202014,028,300 shares $61.86 million +13.0%14.7%7.3 $4.41 2/28/202012,420,000 shares $38.87 million +1.1%13.0%5.7 $3.13 2/14/202012,290,000 shares $46.82 million -3.2%12.8%5.5 $3.81 1/31/202012,690,000 shares $59.14 million +12.1%13.3%5.4 $4.66 1/15/202011,320,000 shares $51.96 million -4.3%11.8%4.7 $4.59 12/31/201911,830,000 shares $47.08 million +32.9%12.4%5 $3.98 CPRX Short Interest - Frequently Asked Questions What is Catalyst Pharmaceuticals' current short interest? Short interest is the volume of Catalyst Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 7,710,000 shares of CPRX short. 7.59% of Catalyst Pharmaceuticals' shares are currently sold short. Learn More on Catalyst Pharmaceuticals' current short interest. What is a good short interest ratio for Catalyst Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CPRX shares currently have a short interest ratio of 6.0. Learn More on Catalyst Pharmaceuticals's short interest ratio. Which institutional investors are shorting Catalyst Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Catalyst Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Catalyst Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.59% of Catalyst Pharmaceuticals' floating shares are currently sold short. Is Catalyst Pharmaceuticals' short interest increasing or decreasing? Catalyst Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 7,710,000 shares, an increase of 23.0% from the previous total of 6,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Catalyst Pharmaceuticals' float size? Catalyst Pharmaceuticals currently has issued a total of 118,110,000 shares. Some of Catalyst Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Catalyst Pharmaceuticals currently has a public float of 101,640,000 shares. How does Catalyst Pharmaceuticals' short interest compare to its competitors? 7.59% of Catalyst Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Catalyst Pharmaceuticals: Agios Pharmaceuticals, Inc. (11.77%), Evotec SE (0.05%), Amphastar Pharmaceuticals, Inc. (11.35%), Keros Therapeutics, Inc. (6.35%), Galapagos NV (2.41%), Syndax Pharmaceuticals, Inc. (11.90%), NewAmsterdam Pharma (0.96%), Ardelyx, Inc. (15.11%), Deciphera Pharmaceuticals, Inc. (11.65%), Amneal Pharmaceuticals, Inc. (2.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Catalyst Pharmaceuticals stock? Short selling CPRX is an investing strategy that aims to generate trading profit from Catalyst Pharmaceuticals as its price is falling. CPRX shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Catalyst Pharmaceuticals? A short squeeze for Catalyst Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CPRX, which in turn drives the price of the stock up even further. How often is Catalyst Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AGIO Short Interest Data EVO Short Interest Data AMPH Short Interest Data KROS Short Interest Data GLPG Short Interest Data SNDX Short Interest Data NAMS Short Interest Data ARDX Short Interest Data DCPH Short Interest Data AMRX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CPRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace